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 INTRODUCTION 
 Influenza virus primarily infects epithelial cells of the upper res-
piratory tract, leading to cell death and acute inflammation. The 
immunological mechanisms controlling the protective response 
against the virus have been the focus of intense research. Indeed, 
specific roles in the protective response have already been attrib-
uted to B cells, distinct dendritic cell (DC) populations, CD4  + 
T cells, and cytotoxic CD8  +  T cells. 1 – 4 Upon infection, lung-
resident DCs migrate to the draining lymphoid tissue and initi-
ate an influenza-specific response through presentation of viral 
antigens to T cells. Additionally, DCs present within the lungs 
are necessary for the activation of effector and memory T cells 
and the consequent clearance of the virus. 5 – 8 
 The airway epithelium is the primary site of influenza virus 
infection and replication. Although epithelial cells are known 
to produce a wide spectrum of inflammatory mediators, the 
significance of their contribution to anti-influenza responses 
is poorly understood. Thymic stromal lympho poietin (TSLP) 
is an interleukin-7 (IL-7)-like cytokine, which is predomi-
nantly produced by epithelial cells. 9 Several cell types includ-
ing DCs and CD4  +  and CD8  +  T cells respond to TSLP. 
To date, TSLP has been studied primarily in the context of 
T helper type 2 (Th2) responses associated with inflammatory 
disorders such as atopic dermatitis and asthma 10 – 12 and protec-
tive immunity to helminth parasites. 13,14 TSLP can induce Th2 
responses either by directly targeting naive CD4  +  T cells or 
indirectly through regulation of DC function. 11,15 Furthermore, 
TSLP has been reported to support the survival of cytotoxic 
T cells both directly 16 and indirectly through the activation 
of DCs. 17,18 Interestingly, viral nucleic acid analogs and 
proinflammatory cytokines associated with active viral infec-
tions are potent inducers of TSLP; 19 – 21 however, it has yet to be 
shown whether TSLP plays a functional role during antiviral 
immune responses. 
 To elucidate the role of TSLP in viral infections, we investi-
gated the immune response against influenza A in mice deficient 
in TSLP receptor (TSLPR). We found that TSLP expression was 
induced at day 5 after infection, suggesting that TSLP may not 
regulate the early innate response to infection but rather adap-
tive immunity. Indeed, the early kinetics of viral propagation 
were unaffected by the absence of TSLPR signaling. However, 
TSLP did play a role in viral clearance at later time points, and 
the virus-specific CD8  +  T-cell response was reduced in the 
absence of TSLPR. 
 This defect was not linked to DC migration or priming of 
virus-specific CD8  +  T cells in the draining lymph node; instead, 
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virus-specific CD8  +  T-cell responses in the lung were impaired. 
We found that TSLP targeted CD11b  +  inflammatory DCs that 
are recruited to the lungs upon infection and boost local CD8  + 
T-cell responses. Specifically, TSLP was required to enhance 
IL-15 production and expression of CD70 by these DCs in the 
lung. We propose that TSLP enhances cytotoxic T-cell function 
in the lung indirectly by affecting the maturation of DCs, which 
are recruited to the lungs upon infection. 
 RESULTS 
 TSLP augments influenza-A-specific CD8  +  T-cell 
responses 
 To investigate the role of TSLP in protective antiviral immu-
nity, we first assessed the expression of TSLP in the lung and 
airways at several time points during infection ( Figure 1a ). 
We found that TSLP expression peaked at day 5 after infec-
tion, which coincided with the maximal pulmonary viral load 
( Figure 1b ). We then proceeded to characterize the response 
against influenza A infection in wild-type C57BL / 6 and TSLP 
receptor (TSLPR)-deficient mice. Analysis of viral load kinetics 
by both quantitative PCR and tissue culture infectious dose 50 
(TCID 50) showed that although early control of viral replica-
tion was comparable between wild-type and TSLPR-deficient 
mice, the absence of TSLP resulted in delayed clearance of 
the virus from day 7 after infection ( Figure 1b ). This was not 
associated with a global reduction in CD8  +  T cells in the air-
ways ( Figure 1c ); however, there was a significant decrease in 
the number of influenza-specific CD8  +  T cells ( Figure 1d ). 
In line with this finding, we observed decreased levels of 
interferon-  production by CD8  +  T cells upon specific 
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 Figure 1   Thymic stromal lymphopoietin (TSLP) is induced during influenza A infection and augments virus-specific CD8  +  T-cell responses. 
Wild-type (WT) and TSLP receptor (TSLPR)-deficient mice were infected intranasally with 50  PFU PR8 influenza A virus. ( a ) TSLP expression was 
determined by real-time PCR at the indicated time points after infection. ( b ) Viral load from whole lung and trachea was determined by quantitative 
real-time PCR. Expression of influenza matrix protein was normalized to   -actin expression at the indicated time points after infection. The tissue 
culture infectious dose 50 (TCID 50) was determined on lung homogenate samples at the indicated time points. Data are pooled from two experiments 
( n  =  3 – 5) and are representative of at least four independent experiments. ( c ) Recruitment of total CD8  +  T cells and ( d ) influenza-specific NP 366 – 374, 
PA, and PB-1 CD8  +  T tetramer  +  cells in the bronchoalveolar lavage (BAL) was assessed by flow cytometry on day 10 after infection ( n  =  5). Data are 
representative of at least three independent experiments. ( e ) BAL cells were restimulated  in vitro by bone marrow-derived dendritic cells (BMDCs) 
pulsed with ultraviolet (UV)-inactivated virus for 6  h before analysis of interferon-  (IFN-  ) production. Data are representative of two independent 
experiments ( n  =  5 – 6). ( f ) Granzyme B expression in total CD8  +  T cells from the BAL was determined by flow cytometry. Solid histogram represents 
fluorescence minus one control. Data are pooled from two experiments ( n  =  4 – 6). Granzyme B expression in tetramer-specific CD8  +  T cells from the 
BAL was determined by flow cytometry. Data pooled from two experiments ( n  =  3 – 6). Error bars represent s.e.m. MFI, mean fluorescence intensity. 
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restimulation ( Figure 1e ) and decreased Granzyme B expression 
by both total ( Figure 1f ) and NP 366 – 374 tetramer-binding CD8  + 
T cells ( Figure 1f ). Taken together, these data demonstrate 
that TSLPR signaling promotes influenza-specific CD8  + 
T-cell responses. 
 TSLP does not regulate the survival of lymphocytes recruited 
to the site of infection 
 TSLP has been previously linked to promoting CD8  + 
T-cell survival  in vivo and  in vitro . 16 To address whether TSLP 
directly enhances the survival of lung-recruited lymphocytes, 
we measured apoptosis and death of total CD8  +  and influ-
enza-specific CD8  +  T cells in the bronchoalveolar lavage 
of mice 10 days after infection ( Figure 2a ). We observed no 
significant differences in the rate of cell death or apoptosis 
of these cell populations. Furthermore, TSLPR-deficient 
influenza-specific CD8  +  T cells expressed significantly higher 
levels of the antiapoptotic molecule Bcl-2 (B-cell lymphoma 2; 
 Figure 2b ), which could be indicative of a less mature activa-
tion state. 22 
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 Figure 2   Thymic stromal lymphopoietin (TSLP) does not regulate survival of lymphocytes recruited to the site of infection. Wild-type (WT) and TSLP 
receptor (TSLPR)-deficient mice were infected intranasally with 50  PFU PR8 influenza virus. ( a ) On day 10 after infection, mice were killed and the 
indicated cell populations infiltrating the bronchoalveolar lavage (BAL) were analyzed for cell death (7-AAD  +  , Annexin V  +  ) and apoptosis (7-AAD  −  , 
Annexin V  +  ) by flow cytometry. 7-AAD, 7-aminoactinomycin D. ( b ) Expression of the antiapoptotic molecule Bcl-2 (B-cell lymphoma 2) was assessed 
in the indicated cell populations by flow cytometry. Data are representative of at least three independent experiments ( n  =  4 – 5). 
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 TSLP acts indirectly to augment influenza-specific CD8  +  
T-cell responses 
 Various hematopoietic cells including DCs and CD8  +  and 
CD4  +  T cells express the TSLPR. Hence, TSLP could act 
directly and / or indirectly on CD8  +  T cells to promote their 
activation. To distinguish the primary target cell of TSLP 
during influenza infection, we generated mixed bone mar-
row chimeras by reconstituting lethally irradiated wild-type 
hosts with a mixture of wild-type congenic (CD45.1) and 
TSLPR-deficient (CD45.2) donor bone marrow in a 1:1 
ratio. At 2 months after reconstitution, chimeric mice were 
infected with influenza virus and the immune response 
in the wild-type or knockout compartment was assessed. 
Wild-type and TSLPR-deficient T cells exhibited com-
parable influenza-specific responses as measured by the 
frequency of tetramer-positive CD8  +  T cells ( Figure 3a ), 
cytokine production ( Figure 3b ), and Granzyme B expres-
sion ( Figure 3c,d ). Moreover, TSLPR-deficient CD8  + 
T cells recruited to the airways following infection did 
not exhibit compromised survival ( Figure 3e ). These data 
demonstrate that TSLP acts indirectly, possibly via antigen-
presenting cells, to boost influenza-specific CD8  +  T-cell 
responses. 
 TSLP does not affect antigen uptake, transport, or priming of 
influenza-specific responses in the draining lymph node 
 We investigated if the absence of TSLP signaling could influ-
ence the uptake of viral antigen by DCs and their subsequent 
migration and presentation to T cells in the draining lymph 
node. Wild-type and TSLPR-deficient mice were infected with 
influenza virus in the presence of fluorescein isothiocyanate 
(FITC)-labeled ovalbumin (OVA) and the ensuing migration 
of airway DCs to the draining mediastinal lymph node was 
monitored. TSLPR-deficient DCs showed no impairment in 
antigen uptake or migration into the draining lymph node 
( Figure 4a ). To assess the capacity of the migrated DCs to acti-
vate specific T cells, we infected wild-type and TSLPR-defi-
cient mice with influenza A (PR8-SIINFEKL) that expresses the 
MHC-I (major histocompatibility complex class I)-restricted 
OVA peptide (amino-acid sequence SIINFEKL). 23 DCs iso-
lated from the lymph nodes of infected TSLPR-deficient mice 
were equally efficient in inducing proliferation of OVA-pep-
tide-specific TCR-transgenic OT-I CD8  +  T cells 24  in vitro 
( Figure 4b ), indicating that TSLPR signaling was not required 
for antigen presentation by DCs in the draining lymph node. We 
also characterized the DC subsets in the draining lymph node 
and observed similar kinetics and expression of costimulatory 
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 Figure 3   Thymic stromal lymphopoietin (TSLP) acts indirectly to augment influenza-specific CD8  +  T-cell responses. Lethally irradiated 
wild-type mice (WT) were reconstituted with bone marrow from WT (Ly5.1) and TSLP receptor (TSLPR)-deficient (Ly5.2) mice in a 1:1 ratio. 
At 8 weeks after reconstitution, chimeric mice were infected with 50  PFU PR8 and influenza-specific responses in the bronchoalveolar lavage 
(BAL) were monitored on day 10 after infection. ( a ) Percentage of CD8  +  T cells from the WT or TSLPR-deficient compartment was analyzed 
by flow cytometry. The percentage of NP 366 – 374 tetramer  +  cells within CD8  +  T cells of either the WT or TSLPR-deficient compartment 
was evaluated. ( b ) Viability of the indicated cells within the WT or TSLPR-deficient compartment was determined by using Annexin V and 
7-aminoactinomycin D (7-AAD). Granzyme B expression in ( c ) total and ( d ) NP 366 – 374 tetramer  +  CD8  +  T cells within the WT or TSLPR-
deficient compartment was measured. MFI, mean fluorescence intensity. ( e ) Cells from the BAL of infected mice were restimulated with bone 
marrow-derived dendritic cells (BMDCs) pulsed with influenza virus for 6  h in the presence of monensin and the proportion of interferon-  
(IFN-  )-producing cells within the WT or the TSLPR-deficient CD8  +  T-cell compartment was determined. Data are pooled from two independent 
experiments ( n  =  3 – 5). 
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molecules ( Supplementary Figure S3 online). In further sup-
port of these data, we found similar frequencies of virus-specific 
CD8  +  T cells in the lung-draining lymph nodes ( Figure 4c ), 
which exhibited comparable capacity to produce proinflamma-
tory cytokines ( Figure 4d ). 
 TSLP acts on DCs and consequently affects local 
reactivation of T cells in the lungs and airways 
 Based on our earlier data we hypothesized that TSLP might 
rather influence local responses at the site of infection. DCs 
present in the lung are critical for the reactivation of effector 
and memory T cells and the consequent clearance of the virus. 6 
Furthermore, they are known to express TSLPR and respond 
to TSLP  in vitro . 15,17,25 Thus, we investigated DC function at 
the site of infection. We found that in contrast to the medi-
astinal lymph node ( Figure 4b ), DCs purified from the lungs 
of influenza (PR8-SIINFEKL)-infected TSLPR-deficient mice 
were compromised in their ability to induce proliferation of 
antigen-specific OT-I CD8  +  T cells ( Figure 5a ). In addition, 
we also observed a similar defect in the TSLPR-deficient DCs 
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to prime effector CD8  +  T cells isolated from the lung of mice 
infected with influenza A ( Supplementary Figure S6 online). 
As DCs shape the inflammatory milieu at the site of infec-
tion, we additionally compared the expression of cytokines 
that are crucial for efficient CD8  +  T cells responses in the 
lungs of mice. Among these, we found that the expression of 
IL-15 was reduced in the TSLPR-deficient mice ( Figure 5b,c ). 
Furthermore, recombinant TSLP enhanced IL-15 expression 
in bone marrow-derived DCs cultured with ultraviolet-irradi-
ated PR8 ( Supplementary Figure S1 online). Reconstitution of 
TSLPR-deficient mice with IL-15 / 15R complex partially restored 
the activation of CD8  +  T-cell response in the lung as character-
ized by Granzyme B expression in influenza-specific CD8  +  T 
cells ( Figure 5d ). In particular, the trans-presentation of IL-15 
by DCs at the site of infection has been shown to regulate local 
virus-specific responses. 26 We tracked different DC subsets 
and their activation states in lungs of infected mice during the 
course of infection ( Figure 5e ,  Supplementary Figures S2, S4, 
and S5 online). Of note was the CD11b  +  DC subset, which 
expressed the highest levels of TSLPR ( Supplementary Figure 
S4 online). Although the recruitment of these cells was similar 
in both wild-type and TSLPR-deficient mice ( Figure 5e ), their 
ability to produce IL-15 was reduced in the absence of TSLPR 
( Figure 5f ,  Supplementary Figure S5 online). This could in 
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part explain the defective pulmonary CD8  +  T-cell responses 
as DC-derived IL-15 is important for the local restimulation of 
CD8  +  T effector cells. 26 
 We also characterized the expression of several costimula-
tory molecules including CD40, CD80, CD86, and CD70, which 
are involved in DC / CD8  +  T-cell interactions. We found that 
TSLP specifically influenced the expression of the costimulatory 
molecule CD70. It has been shown that CD70 expression by 
DCs is important for the generation of influenza-specific CD8  + 
T-cell responses. 27 
 We observed that the expression of CD70 by the CD11b  + 
DCs at day 7 after infection was decreased in the absence of 
TSLPR ( Figure 5g ). Interestingly, TSLP also affected CD70 
expression by the CD11b  −  CD103  +  DC subset ( Supplementary 
Figure S4B online). 
 Taken together, our data indicate that TSLP primarily 
acts to enhance maturation of newly recruited CD11b  +  inflam-
matory DCs by engaging specific pathways, including the pro-
duction of IL-15 and the expression of costimulatory molecule 
CD70. The inflammatory DCs, matured in the presence of TSLP 
during viral infection, are more potent at restimulation of local 
CD8  +  T-cell responses in the lung ( Figure 6 ). 
 DISCUSSION 
 Although TSLP has been shown to directly regulate CD8  + 
T-cell homeostasis, our data from mixed bone marrow chime-
ras indicated that during viral infection TSLP affected CD8  + 
T cells indirectly by signaling on another hematopoietic cell 
type ( Figure 3 ). TSLP is known to regulate DC maturation, 
and our data indicate that it acts locally in the lung to regu-
late the function of newly recruited inflammatory DCs. In line 
with our work, studies utilizing human cells have linked TSLP 
as an adjuvant in BCG (Bacillus Calmette – Gu é rin)-mediated 
antitumor cytotoxic CD8  +  T-cell responses 18 by signaling 
on DCs, although the underlying molecular mechanism of 
this activity remains unknown. 
 DCs are constantly sampling the airways and, on infection, 
transport viral antigen to the draining lymph nodes where they 
initiate protective CD8  +  T-cell responses. Concurrently, DC 
precursors are recruited to the infected lungs, where they dif-
ferentiate locally into various DC subsets. In the lymph nodes, 
both migratory CD11b  −  and CD11b  +  DCs are potent at 
cross-presenting viral antigen. 3,27 The predominant role for 
one subset over the other is attributed to a difference in infec-
tious dose. It is speculated that at a lower dose of infection, 
CD11b  +  DCs infected by the virus do not undergo apoptosis 
and are hence able to migrate and cross-present the antigen 
directly, 27,28 and at higher doses of infections, because of an 
increase in virus-induced cell death, the CD11b  −  DCs cross-
present antigen more owing to their ability to phagocytose 
apoptotic cells. 3,27,28 
 In our study, which also uses a low dose of infection, the 
initiation of influenza-specific CD8  +  T-cell responses 
in the lymph node was independent of TSLP. The differ-
ent DC subsets migrated to the draining lymph nodes 
with similar kinetics and expressed similar if not even 
higher levels of costimulatory molecules in the TSLPR-defi-
cient mice ( Figure 4 ,  Supplementary Figure S3 online). 
Consequently, the influenza-specific T-cell responses in 
the lymph node were unaltered. We also observed that 
CD11b  +  DCs provided costimulation via CD70 in the lymph 
nodes, 27 but this was independent of TSLP ( Supplementary 
Figure S3 online). TSLP expression peaked at day 5 after 
infection, coinciding with the peak of the viral replication 
and the transition from the innate to the adaptive immune 
response in the lung ( Figure 1a ). 
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 Figure 6   Thymic stromal lymphopoietin (TSLP) enhances pulmonary influenza-specific CD8  +  T-cell responses. ( a ) TSLP does not affect the 
initiation of adaptive immune response in the draining lymph node. ( b ) It acts on CD11b  +  inflammatory DCs recruited to the lung and ( c ) induces the 
production of interleukin-15 (IL-15) and expression of CD70, which enhances influenza-specific CD8  +  T-cell responses. 
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 It is likely that the maturation of the DCs that migrate to the 
lymph nodes is dependent on factors preceding TSLP expression 
in the lung. Thus, the reduced pulmonary influenza-specific 
CD8  +  T-cell response in the TSLPR-deficient mice resulted 
from the absence of signaling of TSLP on cells within the lung. 
 The effector CD8  +  T cells, which are recruited to the lungs, 
require an additional interaction with the DCs in the lung. 6,7,29 
Indeed, TSLPR-deficient DCs isolated at day 7 from infected 
lungs showed an impaired ability to prime antigen-specific 
T-cell responses ( Figure 5a ,  Supplementary Figure 6 online). 
As different DC subsets have been attributed specific functions 
during infection, 28 we investigated whether TSLP targets a spe-
cific DC subset in the lungs. Monocyte-derived CD11b  +  DCs 
are the predominant population when the first effector CD8  + 
T cells get recruited to the lungs. 1,2 A subpopulation of the 
CD11b  +  DCs, the tip DCs, are also proposed to support the 
local proliferation of effector CD8  +  T cells in the lungs. 30 In 
our study the CD11b  +  DC subset expressed the highest level 
of the TSLPR and was thus likely to be more responsive to cues 
from TSLP ( Supplementary Figure S4A online). In line with 
this, TSLP specifically targeted the function of these DCs by 
influencing expression of the costimulatory molecule CD70 as 
well as the production of IL-15 ( Figure 5f,g ). Costimulation 
via CD70 on CD11b  +  DCs licenses them to expand CD8  +  T 
cells in the lymph node, 27 but their function in the lung has 
not been addressed before. We observed that TSLP affected 
the expression of CD70 by inflammatory CD11b  +  DCs in the 
lungs ( Figure 5g ). We also saw a similar defect in the CD11b  − 
DCs in the lung, although they expressed much lower levels of 
CD70 in comparison with the CD11b  +  DCs ( Supplementary 
Figure S4B online). The expression of other costimulatory mole-
cules such as CD40, CD80, and CD86 by various DC subsets 
in the lungs was unaffected in the absence of TSLPR signaling 
( Supplementary Figure S4 online). As in the lymph nodes, 27 
CD8  +  T effector cells recruited to the lungs might also exhibit 
a differential requirement for costimulatory molecules and pos-
sibly a greater dependence on costimulation via CD70. 
 Another pathway affected by the absence of TSLPR signaling 
on the CD11b  +  DCs was the production of IL-15. Trans-pres-
entation of IL-15 by pulmonary DCs has been shown to regu-
late CD8  +  T-cell survival within the lung following influenza 
infection. 26 However, this study focused on early time points 
and not at the peak of the effector response. In other settings 
of inflammation, IL-15 has been reported to activate antigen-
specific CD8  +  T cells. 31,32 
 We observed that TSLPR signaling acted to directly promote 
IL-15 expression in DCs  in vitro ( Supplementary Figure S1 
online). We then followed the kinetics of IL-15 production dur-
ing the course of influenza infection and found that the produc-
tion of IL-15 is compromised in the absence of TSLPR signaling 
( Figure 5c ). 
 Interestingly, although we were able to detect differences in 
mRNA expression of IL-15 from total lung cells only at day 7 
and day 10, we observed differences in the protein levels (IL-15 
and IL-15 / IL-15R  complexes) as early as day 5 after infection. 
To consider whether temporal differences in the source of IL-15 
in the lungs accounted for this inconsistency, we purified dif-
ferent cells from infected lungs and looked at the expression of 
IL-15 mRNA. We were able to detect differences in the expres-
sion of IL-15 in the CD11b  +  DCs even at day 5 after infection 
( Supplementary Figure S5A online). At this time, we observed 
that sorted cell fractions containing macrophages and plasma-
cytoid DCs also expressed IL-15 but this was independent of 
TSLPR deficiency ( Supplementary Figure S5A online). As a 
decreased expression of IL-15 mRNA by CD11b  +  DCs cor-
related with the decreased protein levels, this suggested that 
the CD11b  +  DCs were the chief producers of IL-15. In further 
support, the expression of IL-15R  , which is believed to faith-
fully represent the production of IL-15, 26 is also highest on the 
CD11b  +  DCs ( Supplementary Figure S5B online). 
 Both CD70 and IL-15 are crucial for influenza-specific 
CD8  +  T-cell responses, although via different pathways. 26,27 
Engagement of the CD70 ligand 27 on CD8  +  T cells has been 
shown to aid in proliferation, whereas IL-15 has been shown to 
influence the survival 26 of effector CD8  +  T cells recruited to the 
lung. We partially restored the CD8  +  T-cell function by admin-
istering IL-15 complexes in the TSLPR-deficient mice. This sug-
gested that these pathways are regulated by TSLP independently 
of each other. Furthermore, TSLP enhanced the expression of 
CD70 on both CD11b  −  and CD11b  +  DCs in the lung, whereas 
it specifically boosted IL-15 expression by the CD11b  +  DCs. 
 In conclusion, we show a novel role for TSLP in engaging 
distinct activation pathways of CD11b  +  inflammatory DCs 
during influenza infection and consequently augmenting anti-
viral CD8  +  T-cell responses. 
 METHODS 
 Mice and infections .  C57Bl / 6 mice aged between 8 and 14 weeks were 
purchased from Charles River (l ’  Arbresle Cedex, France), whereas trans-
genic OT-I mice and TSLPR-deficient mice were bred locally. Influenza 
virus strain PR8 (A / Puerto Rico8 / 34, H1N1) was sourced from Virpur 
(Virapur LLC, San Diego, CA). Viral infections were performed by intrana-
sal administration of 50  PFU of virus in 50   l of phosphate-buffered saline. 
Animal experiments were performed in accordance with the institutional 
guidelines and Swiss federal and cantonal laws on animal protection. The 
reverse engineered influenza PR8 SIINFEKL strain 23 was kindly provided 
by Dr Richard Webby (St Jude Children ’ s Research Hospital, Memphis, TN). 
 TCID 50 assay .  Influenza virus was quantified from lung homogenate 
using the TCID 50 assay. 33 MDCK (Madin-Darby canine kidney) cells 
were infected overnight with tissue homogenate and incubated for 5 days 
at 37  ° C. At the end of 5 days, infectious virus was quantified by add-
ing gluteraldehyde-fixed guinea pig red blood cells and TCID 50 was 
calculated for each sample by reading the virus-induced agglutination 
of red blood cells. 
 In vivo DC tracking .  Wild-type and TSLPR-deficient mice were admin-
istered 50   g Ova-FITC (Invitrogen, Grand Island, NY) together with 
50  PFU PR8 intranasally. Migration of airway DCs transporting Ova-FITC 
to the lung-draining lymph node was monitored by flow cytometry. 
 Antibodies and flow cytometry .  Different combinations of the following 
antibodies were used for flow cytometry. For analysis of DC subsets in 
the lung a combination of CD11b PerCP-Cy5.5, CD11c APC-Cy7, B220 
FITC, Ly6c pacific blue, NK1.1 PE-Cy7, MHC II Alexa Fluor 700, PDCA-
1 Alexa Fluor 647, CD103 PerCP-Cy5.5, CD40 PE, CD70 PE, CD80 PE, or 
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CD86 PE was used. TSLPR and IL-15R  antibodies were purchased from 
R & D (Minneapolis, MN). Influenza-specific CD8  +  T cells were stained 
with NP tetramer 366 – 374, PA, and PB1 generated in-house. For detect-
ing cell death and apoptosis, a combination of Annexin V and 7-AAD 
(7-aminoactinomycin D) was used. Intracellular staining was performed 
to detect the expression of Bcl-2, interferon-  , and Granzyme B. 
 All antibodies were purchased from Biolegend (San Diego, CA) unless 
indicated. Stained cells were acquired on a BD FACS Calibur or BD FACS 
CANTO or BD FACS LSR II (Franklin Lakes, NJ) and analyzed on FlowJo 
software (Tree Star, Ashland, OR). 
 Ex vivo restimulation of specific CD8  +  T cells .  Bone marrow-derived 
DCs were pulsed with ultraviolet-irradiated influenza virus overnight. 
The following day, cells from the bronchoalveolar lavage of infected 
mice were cocultured with them for 6  h in the presence of monensin 
and assessed for the production of interferon-  by flow cytometry. 
 In vitro coculture of DCs and CD8  +  T cells .  DCs were isolated by 
positive selection with CD11c  +  beads (Miltenyi Biotech, Bergisch 
Gladbach, Germany) from infected lungs and put in culture with either 
MACS-sorted naive splenic CD8  +  T cells or effector CD8  +  T cells from 
infected lungs in a ratio of 1:5. Proliferation was determined by dilution of 
carboxyfluorescein succinimidyl ester-labeled CD8  +  T cells. 
 In vivo reconstitution of IL-15 .  IL-15 complexes were generated as 
described previously. 34 A total volume of 1.5   g of IL-15 complexed with 
7   g of IL-15R  was administered intranasally in a volume of 78   l per 
mouse at day 9 after infection. The analysis was performed 24  h after 
administration of the IL-15 complex. 
 Enzyme-linked immunosorbent assay .  IL-15 levels in lung homo genate 
of infected mice were determined using IL-15 ELISA DuoSet from R & D 
systems. 
 Generation of mixed bone marrow chimeras .  Lethally irradiated wild-
type mice were reconstituted with bone marrow from wild-type (Ly5.1) 
and TSLPR-deficient (Ly5.2) mice in a 1:1 ratio. Chimeric mice were 
infected 8 weeks after reconstitution. 
 Quantitative real-time PCR .  Total RNA was purified from cells obtained 
from whole lung and trachea of mice using Tri reagent. Real-time PCR was 
carried out according to the manufacturer ’ s instructions using the quan-
tifast SYBR green RT-PCR kit (Qiagen, West Sussex, UK). The following 
primers were used: IL-15 forward, 5  -CATCCATCTCGTGCTACTTGTG
TT-3  ; IL-15 reverse, 5  -CATCTATCCAGTTGGCCTCTGTTT-3  ; 
TSLP forward 5  -AGAGAAGCCCTCAATGACCA-3  ; TSLP reverse 
5  -TCTGGAGATTGCATGAAGGA-3  ; GAPDH forward 5  -GGGTGT
GAACCACGAGAAAT-3  ; GAPDH reverse 5  -CCTTCCACAATGC
CAAAGTT-3  ; Influenza matrix protein forward 5  -GGACTGCAG
CGTAGACGCTT-3  , reverse 5  -CATCCTGTTGTATATGAGGCCC
AT-3  ;  β actin forward 5  -CCCTGAAGTACCCCATTGAAC-3  ; 
 β actin reverse 5  -CTTTTCACGGTTGGCCTTAG-3  . Expression was 
determined either by using absolute quantification or by compa rative 
  -threshold cycle method using GAPDH as a comparator. IL-15 
and TSLP expression is represented as fold change relative to naive lung 
sample. 
 Flow cytometric sorting of DC subsets .  Wild-type and TSLPR-deficient 
mice were infected with 50  PFU PR8 intranasally. Lungs from 3 to 4 
mice were pooled and stained for sorting by flow cytometry. DC subsets 
were gated as described ( Supplementary Figure S5 online) and sorted 
into Trizol (Invitrogen). RNA was isolated from the different sorted 
populations and real-time PCR was carried out as described above. 
 Statistical analysis .  Student ’ s  t -test (unpaired, two tailed) was used to 
calculate significance levels between treatment groups. The  P- values 
of   <  0.05 were considered significant. Graph generation and statistical 
analyses were performed using Prism version 5 software (GraphPad, 
La Jolla, CA). Standard error of the mean was used. 
 SUPPLEMENTARY MATERIAL is linked to the online version of the 
paper at  http://www.nature.com/mi 
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